Related Experiment Video
Updated: May 2, 2026
13:04
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
23.7K
The relation between hepatitis C virus and coronary heart disease
Amr Hany Metwally1, Mohamed-Adel F Elgamal1
1Mansoura University, Mansoura, Egypt.
Medical Hypotheses
|February 25, 2014
Summary
Chronic hepatitis C (HCV) infection unexpectedly does not increase myocardial infarction risk. Instead, HCV may offer cardiovascular protection through mechanisms like lower cholesterol and altered clotting, warranting further investigation.
Area of Science:
- Hepatology
- Cardiovascular Medicine
- Metabolic Syndrome
Background:
- Chronic hepatitis C is linked to insulin resistance and metabolic syndrome, known risk factors for atherosclerosis and coronary heart disease.
- Metabolic syndrome often increases the risk of myocardial infarction (heart attack).
Purpose of the Study:
- To hypothesize the mechanisms by which Hepatitis C Virus (HCV) infection does not increase myocardial infarction risk.
- To explore potential cardiovascular protective effects of HCV infection in patients with metabolic syndrome.
Main Methods:
- Literature review and hypothesis generation.
- Analysis of known physiological changes associated with chronic hepatitis C infection.
Main Results:
- HCV infection is not associated with an increased risk of myocardial infarction.
- Proposed mechanisms include decreased cholesterol and LDL, altered blood clotting, impaired myocardial function, reduced venous return, increased nitric oxide and TNF alpha, and diminished cardiac beta receptor signaling.
Conclusions:
- HCV infection may confer a protective effect against cardiac ischemia and coronary heart disease.
- Further studies are needed to validate these proposed protective mechanisms against cardiovascular risks.
Related Concept Videos
01:25Hepatitis
86
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
86
01:28Viral Hepatitis I: Introduction
25
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
25
01:26Coronary Artery Disease II: Pathophysiology
1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
01:26Coronary Artery Disease IV: Preventive Measures
890
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
01:30Coronary Artery Disease I: Introduction
1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
01:27Coronary Artery Disease V: Interprofessional Care
444
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444